SEC Form 4 · accession 0001209191-15-003714
CRESCENT BIOPHARMA, INC. · CBIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brian M. Hahn
Officer — CFO
Period of report
Jan 8, 2015
Accepted (ET)
Jan 12, 2015 · 4:52 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001253689
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $7.15 | Jan 8, 2015 | A | 61,000 | A | — | Jan 7, 2025 | Common Stock | 61,000 | 61,000 | D |
Explanation of responses
- F1One-fourth of the shares underlying this option vest on January 8, 2016 and the balance of the shares vest in a series of 36 successive equal monthly installments thereafter, subject to the reporting person's continuous service as of each such vesting date.